Lebende Larven von Lucilia sericata (1) – BioBag, BioMonde Freie Larven®, BioMonde® Freie Larven

Chronic or hard to heal wounds

Characteristics

Start date 01.06.2014
Resolution 20.11.2014
INN Lebende Larven von Lucilia sericata
Brand name BioBag, BioMonde Freie Larven®, BioMonde® Freie Larven
Pharm. company BioMonde GmbH
G-BA Procedure ID D-115
ATC code D03AX32 Other cicatrizants (D03AX)
ICD-10 codes (AIS) T89.00, T89.03
Alpha-ID codes (AIS) I15676Poorly healing wound
Therapeutic area Other diseases Wound care / Debridement
Reason for procedure Initial assessment

Therapeutic indication of the resolution

Debridement of chronic or hard-to-heal wounds when instrumental surgical treatment is not desired.

Subpopulation Indication Comparator
Patients with sloughy chronic or difficult-to-heal wounds when instrumental surgical treatment is not desired. Patient-specific appropriate debridement technique of the physician's choice.

Studies and Results

No. of studies
(best subpopulation)
0 (no data submitted)
Study design
(best subpopulation)
no data submitted (Dossier: )

Debridement of infected chronic or severe slow-healing wounds where surgical treatment using instruments is not desired

  • As the necessary proof has not been provided, the additional benefit in relation to the appropriate comparator therapy is deemed not proven (Section 35a(1), fifth sentence, of Book V of the Social Code [SGB V]).
  • Appropriate comparator therapy
    • The appropriate comparator therapy for the debridement of infected chronic or severe slow-healing wounds is a debridement technique suitable for the individual patient, as chosen by the doctor.
    • Criteria for selecting the debridement technique include, amongst other things, the type of wound, as well as its location and size.

Courtesy translation only, please refer to the German original.

Associated procedures

Lebende Larven von Lucilia sericata (1) BioBag, BioMonde Freie Larven® BioMonde GmbH Other diseases Chronic or hard to heal wounds 500,000–1,000,000 100% additional benefit not proven


<< List of all resolutions